Mary M Mitchell
Overview
Explore the profile of Mary M Mitchell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
289
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chan K, Mitchell M, Casselle E, Bender A
AIDS Educ Prev
. 2024 Feb;
36(1):60-72.
PMID: 38349350
The Centers for Disease Control and Prevention recommends PrEP (pre-exposure prophylaxis) for people who use drugs, yet uptake remains low. This study explores the acceptability and potential uptake of PrEP...
2.
Mitchell M, Mitchell S, Brooks J, Akinwolere O, Dusek K, OGrady K, et al.
Subst Use Misuse
. 2023 Dec;
59(3):329-335.
PMID: 38063201
Vaping, including vaping cannabis, is increasing among adolescents. In this longitudinal study, we examined the relationship between vaping cannabis and frequency of cannabis use and related problems over 6 months...
3.
Tseng T, Mitchell M, Chander G, Latkin C, Kennedy C, Knowlton A
AIDS Behav
. 2023 Dec;
28(2):429-438.
PMID: 38060111
Chronic pain is prevalent and often under-addressed among people with HIV and people who use drugs, likely compounding the stress of discrimination in healthcare, and self-medicating along with its associated...
4.
Mitchell M, Angelo S, Akinwolere O, Perkins M, Bender A
J Subst Use Addict Treat
. 2023 Oct;
156:209187.
PMID: 37858796
Rationale: Public stigma surrounds individuals who use medication for their recovery from a substance use disorder. However, we know little about subgroups of individuals with varying levels of perceived stigma...
5.
Mitchell M, Tseng T, Rubin L, Cruz-Oliver D, Catanzarite Z, Clair C, et al.
AIDS Care
. 2023 Jun;
36(3):358-367.
PMID: 37345842
Vulnerable persons living with HIV (PLWH) are at high risk of cognitive impairment and challenges accessing quality social support in later life. Impaired verbal fluency (VF), a cognitive domain linked...
6.
Mitchell M, Tseng T, Cruz-Oliver D, Catanzarite Z, Hansen E, Knowlton A
AIDS Educ Prev
. 2022 Apr;
34(2):158-167.
PMID: 35438542
Adherence to antiretroviral therapy (ART) is vital for reducing racial and gender disparities in morbidity and mortality among people living with HIV/AIDS (PLWH). Little research attention has been given to...
7.
Mitchell M, Schwartz R, Choo T, Pavlicova M, OGrady K, Gryczynski J, et al.
Drug Alcohol Depend
. 2020 Dec;
219:108422.
PMID: 33352487
Background: The distinct pharmacological properties and clinical uses of extended-release naltrexone (XR-NTX) and sublingual buprenorphine-naloxone (BUP-NX) present challenges in analyzing patient outcomes. Methods: We conducted a secondary analysis of a...
8.
Knowlton A, Nguyen T, Isenberg S, Tseng T, Catanzarite Z, Mitchell M, et al.
AIDS Behav
. 2020 Jul;
25(2):360-376.
PMID: 32715410
Literature on health-related quality of life (HRQOL) has focused on people living with chronic conditions, with less attention given to HRQOL among informal caregivers. We used cross-sectional dyadic data from...
9.
Mitchell M, Gryczynski J, Mitchell S, Kelly S, OGrady K, Monico L, et al.
AIDS Behav
. 2019 Nov;
24(6):1776-1783.
PMID: 31748939
Adults entering pre-trial detention who inject drugs are at high risk for acquiring HIV/AIDS. In the current study, we examined pre-incarceration HIV risk behaviors among 114 people with opioid use...
10.
Mitchell M, Mendelson J, Gryczynski J, Carswell S, Schwartz R
Am J Drug Alcohol Abuse
. 2019 Oct;
46(3):297-303.
PMID: 31596648
Background: Alcohol use disorder (AUD) treatment remains greatly underutilized. Innovative strategies are needed to improve AUD treatment access and patient engagement. The Ria Treatment Platform (RTP) is a patient-centered telemedicine...